EcoDrugPlus

Tubulin Alpha 4a

Ensembl ID : ENSTNIG00000010618
Gene Symbol: TUBA4A
2 Cross references
169 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSTNIG00000010619
Gene Symbol: TUBA4A
2 Cross references
169 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSTNIG00000007046
Gene Symbol: TUBB1
2 Cross references
184 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSTNIG00000015197
Gene Symbol: TUBB2
2 Cross references
305 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSTNIG00000008014
Gene Symbol: TUBB5
2 Cross references
202 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSTNIG00000013517
Gene Symbol: TUBB6
2 Cross references
141 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSTNIG00000009951
Gene Symbol: TYR
3 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSTNIG00000005655
Gene Symbol: TYR
2 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSTNIG00000010465
Gene Symbol: TH
2 Cross references
187 Possible Orthologues:

Utrophin

Ensembl ID : ENSTNIG00000012259
Gene Symbol: UTRN
2 Cross references
270 Possible Orthologues:

V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog

Ensembl ID : ENSTNIG00000012154
Gene Symbol: KRAS
2 Cross references
207 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSTNIG00000004502
Gene Symbol: AKT2
2 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).